Professor Martin Yarmush received a $447,816 grant from Lifeblood Medical Inc. and DOD to test Lifeblood Medical's perfusion solutions for preservation of ischemic livers. The proposed work has significant military relevance, as a superior preservation modality would enable transportation & allocation of donor organs to the troops on foreign battlegrounds, a task which cannot be achieved currently.